Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He’s thinking $12.375 now. Hope he’s right.
I agree people will continue to hold short thinking this will ultimately fail.
I’ll have to disagree with you on the short squeeze theory. I think those people who shorted at the $1.50 range already got out. Based on Interactive Brokers, the average short is 155 calendar days which is about April 10 when it was trading at roughly .55. They account for about 15 million of the roughly 40-45 million reported shorts. We’re right about 25 days to cover based on average volume. I think if you see those positions unwind at the same time as consistent buying based on a catalyst (partnership?) we could see a huge move.
I won’t get into the naked shorts as I’m not a big believer in that.
I have a feeling it breaks above right before market close. Of course, the .70s will be a distant memory in a month.
Reverse splits get a bad rep because they’re generally done by bad companies. They’re not inherently bad. If done with good news, you will not see the stock being taken down.
Just looked at the interactive brokers info again. Someone borrowed around 95k shares this morning that have been returned. The interesting thing is that all 15 million shares available to short are coming from 0-5 lenders and the shorting is being done by 6-10 borrowers. I would be interested to see what happens if those few lenders stopped allowing their shares to be borrowed.
I agree. Submittal and approvals are important for the Company to grow. However, the bears may continue to push down on the SP with various theories until substantial revenue begins to come in regardless of approvals. A partnership with guaranteed money changes everything. At that point, the notion that they can push the Company into bankruptcy is gone.
There was some guidance published earlier on this board about how the UK is pushing approval of trial designs. The UK could be a great place for them to quickly starts trials with a partner.
I honestly don’t know why anyone sells short. The risk/reward seems out of balance to me. Maybe it’s a rigged game where they have a way out? Or they make so much doing this as a practice that an occasional loser is expected? With all the information out there, this is definitely not a stock to short.
Submission
Combo Deal
MTD
I have a MTD filed at the end of June. I’m still waiting for a decision. 5-6 months for a decision is not uncommon. This all depends on the Court but I would be surprised if we get a decision on the MTD this year.
I have some shares held with Interactive Brokers and saw some interesting information. There is currently 167,533 shares available to short with 98.91% of the total inventory loaned. That means there’s roughly 15 million shares sold short on interactive brokers. The average duration is 141 days which would be about April 18 when the share price was .55. The margin requirement is 387%. It looks like the average short position is now underwater. Every .01 this goes up requires the shorts to have almost .04 in maintenance margin available. This seems like a scenario where a short squeeze occurs with a good PR.
I think we get close to $1.50 before the end of the month. Submittal should get us close to the $3 range.
I’m hoping the deal doesn’t involve equity. Even a relatively small deal with $100-$200 million prepayment should do wonders for the stock. It takes away the perceived Bankruptcy risk, dilution worries and the rest of the ridiculous bear arguments. A PR coming from someone like Merck will be seen by much more investors than any PR sent out by NWBO. Could trigger a short squeeze.
Yes, I hope it happens sooner than later. I have friends that are not very sophisticated when it comes to stocks. They use Robinhood which does not allow OTC purchases. I’m sure there is a lot of retail out there that don’t know how to buy OTC stocks. As we’ve seen with the meme stocks, retail can cause large moves these days. Getting us back to a major exchange can definitely open up the doors to new buyers.
I believe they will wait until early next year for the ASM. We should have MAA approval and partnership(s) by that time. We might even no longer be OTC at that point.
They don’t have a choice. This will be over $3 after MAA approval. Should be close to $3 on submission alone. Any partnership announcement with BP will get it there as well.
Sorry to break it you, but you won’t see .50 ever again
You’re right. Completely unavoidable. Do you think anyone here is going to care when they need to raise $50 million at $5 a share?
It’s possible but is retail that dumb? I have zero medical background but was sending screenshots to a fellow Doctor investor. I thought results were good. He confirmed. There was a slide that said they met the endpoints with statistical significance. It’s hard for me to believe that retail was able to get the whole presentation and we’re stuck on that one negative slide.
The share price was dropping even before the results were announced. Was that due to confusion over PFS? Or was something else going on? I watched the presentation live. I liquidated pretty much every other stock I owned and invested it in NWBO that day. Since then, I continue to buy. I believe the SP will be substantially higher by the end of the year. If I’m wrong? It’s only money.
Liabilities are less than 1/10th the market cap taking out insider debts and contingent liabilities. Absolutely no reason clean up the balance sheet with a Bankruptcy.
Unless OTC stocks are not considered part of the stock market, the quote fits.
“The stock market is a device for transferring money from the impatient to the patient.”-Warren Buffet
I’m convinced this will not move up until news of an application being accepted or a partnership being announced. I just picked up more shares today. Either you believe applications will be filed or you believe it’s a scam.
.46 or $1, it doesn’t matter. Approvals and partnerships are all that matter. If this gets approved or enters into a partnership with BP, the share price will be much higher. I’m betting that both will occur and continue to buy.
I’m wondering if these partnerships negotiations have something to do with Al Musella taking down his video with LL. He said he was threatened with legal action. He also mentioned by the time he could talk about it, it wouldn’t matter anymore. A lot of people thought NVCR was behind the threat. Maybe it was Merck and they wanted to keep the trial data private so they wouldn’t have competition?
The potential revenue is 100 times greater. That’s the difference between the 2 stocks so you’re comparing apples to oranges.
That is a separate issue. Do you think DCTH is going to scale up to $40 million immediately? The stock market is forward looking.
They anticipate 40 million in revenue a year, we expect about 4 billion. I’ll let you figure out the difference.
Thermo, do you have any opinion as to what you think the Company is worth post approval?
I think this lines up with what Les said on the show. I don’t think he forgot to mention the US. They will probably wait for other approvals or a partnership prior to filing in the US.
I didn’t say you did. I said that was the post I was responding to.
They have no credibility yet you’re the one flip flopping in a week?
That’s a possibility but not likely. What probably would have happened is many short term holders would have dumped millions of shares causing the share price to drop into the .40s in January. All dilution occurring from January to September would be done at that level. MIA approval would have had a negligible effect. We would still be at the same levels or lower today. We would see the stock price rise as we approached Q4. Is that scenario better then what has occurred?
Thanks for pulling the quotes. That’s exactly what I was referring to.
The argument was the stock was going to zero and they were getting worthless shares. Now you’re argument is they are purposefully holding the SP down so they can continue to accumulate? Great theory. Maybe you’re right. Buy more.
You know what would help the stock price? Submissions and approvals. Two things that we don’t yet have. There is nothing they can say that will have a lasting effect on the stock price other than submission or approval. Only a fool would think a PR from the company stating they are working on applications would have a dramatic effect on the stock price.
Are you surprised by no submission? If you were expecting news of submission in a 10Q then you were setting yourself up for a letdown.
How do you know that more communication wouldn’t result in a lower share price? What do you think would’ve happened to the share price if they came out at the ASM and said applications wouldn’t be submitted until Q4 2023?
Yes because some people have integrity. Didn’t she get into this because her father passed away from GBM? For a 30 year plus attorney Harvard grad, 700k is not that much money. Weren’t you also complaining about advent being owned by her? Why would advent take worthless shares as compensation? Your explanation doesn’t make any sense.
So LP and management, who are shareholders themselves, don’t care about SP? They must be actively working against their own self interests. Makes complete sense. Ever take a step back and think maybe your expectations of management are unreasonable? What happened to your SP reversal prediction from Friday? Going back to your .375 prediction again?
No reason for anyone to bother worrying about this 10Q. Nothing has changed. Applications, approvals and reimbursements. Those are what will drive the SP. Specials revenue? Doesn’t matter. Dilution? Doesn’t matter. Partnerships? Doesn’t matter because they won’t come until after application submittal at the earliest. There has been no fundamental change based on what was disclosed in this 10Q.
In the big picture, this difference isn’t much to lose sleep over. If they were to dilute to receive $50 million (about 1 year operating expenses) at this level, that would be approximately 100 million shares. At $2, 25 million shares. Using 1.2 billion as the current shares outstanding, its around a 5% affect.